November, 2024
According to the Sepsis Alliance survey report published in 2024, around 66% of people in the U.S. were aware of sepsis in 2022, which increased to 69% in 2024. The sepsis therapeutics market deals in the manufacturing and distribution of various medicines for treating sepsis across the world. In October 2023, the Association of American Medical Colleges announced that Sepsis is the third leading cause of death in the U.S. It also stated that around 1.7 million people in the U.S. acquire sepsis every year. The main drugs available in this industry consist of aminoglycosides, cephalosporin, glycopeptide, and some others. The increasing cases of sepsis around the world have boosted the market growth.
This market is generally driven by the rising developments related to sepsis treatment along with technological advancements in diagnostics platforms. Also, the growing awareness regarding the prevalence of sepsis among people is expected to boost the growth of the sepsis therapeutics market.
The advancement in nanotechnology along with rise in research and developments of biomarkers and biozymes is expected to create ample growth opportunities for the market players in the upcoming days. In June 2024, Magnolia Medical launched Magnolia Analytics. It is a diagnosis platform designed to streamline data capture and assess the cost-effectiveness of sepsis misdiagnosis prevention.
This market comprises several players, such as Bayer AG, Abbott Laboratories, AstraZeneca, Gilead Sciences, and others. Abbott Laboratories is a leading provider of sepsis therapeutics, and its overall revenue stood at US$ 40,109 million in 2023.
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form
URL TO BE USED AS REFERENCE LINK:
Placeholder content for this accordion, which is intended to demonstrate the .accordion-flush class. This is the first item's
accordion body.
Placeholder content for this accordion, which is intended to demonstrate the .accordion-flush class. This is the second item's
accordion body. Let's imagine this being filled with some actual content.
Placeholder content for this accordion, which is intended to demonstrate the .accordion-flush class. This is the third
item's accordion body. Nothing more exciting happening here in terms of content, but just filling up the space to make it look, at least at
first glance, a bit more representative of how this would look in a real-world application.
Do you still any question?
Feel free to contact us anytime using our contact form or visit our FAQ page.
Your contact to the Infographics Newsroom
